NCT05775172

Brief Summary

Gastric myoelectric, inflammatory, and hormonal responses, body compositional, energy expenditure, and metabolic changes during the development of obesity and the weight loss process are underinvestigated. This project studied the myoelectrical inflammatory and hormonal responses of the stomach, in addition to energy expenditure and body composition changes during weight loss via bariatric surgery and lifestyle intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

March 3, 2023

Last Update Submit

March 7, 2023

Conditions

Keywords

gastric myoelectric activityInflammatorybariatric surgerylifestyle interventionweight lossbody composition

Outcome Measures

Primary Outcomes (5)

  • Gastric myoelectric activity

    The gastric myoelectric activity was measured in fasting (for 10 mins) and post-prandial state (for 30 mins) using a multichannel electrogastrography (EGG) with a water load satiety test

    6 months

  • Inflammatory changes

    Serum levels of inflammatory markers involving interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), and monocyte chemoattractant protein (MCP-1),

    6 months

  • Body composition measurement

    Body composition was analyzed via a multi-Frequency segmental bioelectric impedance analysis monitor

    6 MONTHS

  • Resting Energy Expenditure

    Resting metabolic rate (RMR) was measured by the automated metabolic cart indirect calorimetry (IC) using a standard canopy hood

    6 MONTHS

  • hormonal analysis

    serum levels of ghrelin, gastrin, and irisin (ELISA kits MyBiosource, San Diego, CA, USA; Catalog numbers: MBS2700428, MBS264399, MBS2600406, respectively).

    6 Months

Study Arms (3)

Waitlist control

Waitlist control (C group n=30) did not achieve any significant weight loss and did not follow lifestyle intervention

Other: Control

Lifestyle intervention

Lifestyle intervention (LS group, n=22) follows multimodal lifestyle intervention in form of 500-100 kcal deficit , gradual physical activity and some behavioral modifications

Dietary Supplement: Lifestyle intervention

Bariatric surgery

Bariatric surgery (BS group n=27) undergoes laparoscopic sleeve gastrectomy

Procedure: Sleeve gastrectomy

Interventions

laparoscopic sleeve gastrectomy was done under general anesthesia by the same surgeon in the SBAHC. Routine preoperative, and postoperative care (including early post-operative dietary management) were done. Baseline assessment was taken within the last week before the surgery during the preoperative preparation and the final assessment was recorded 6 months after the surgery date.

Bariatric surgery
Lifestyle interventionDIETARY_SUPPLEMENT

balanced 500 to 1000-calorie-deficit diet, personalized physical activity plan, and customized behavioral modification

Lifestyle intervention
ControlOTHER

No interventions were applied

Waitlist control

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

A total of 79 participants were randomly assigned to three groups: bariatric surgery (BS group n=27), lifestyle intervention (LS group, n=22), and waitlist control (C group n=30). The participants in the three groups were similar in BMI (\>35 kg/m2), age (18-40 years), and gender. Inclusion criteria included BMI \> 35 kg/m2, and being free of any acute medical condition, malignancy, or psychiatric disorders. Participants taking weight-losing pharmacotherapy or who underwent previous bariatric surgery were excluded. For all participants, electrogastrography, inflammatory cytokines measurements, body composition analysis, dietary assessment, and indirect calorimetry (as described in objective 1) were done at baseline, and after 6 months.

You may qualify if:

  • BMI \> 35 kg/m2,
  • Being free of any acute medical condition, inflammatory conditions, malignancy, or psychiatric disorders

You may not qualify if:

  • Taking weight-losing pharmacotherapy
  • Who underwent previous bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Applied Medical Sciences

Riyadh, 11433, Saudi Arabia

Location

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Mahmoud Abulmeaty

    King Saud University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 3, 2023

First Posted

March 20, 2023

Study Start

June 1, 2021

Primary Completion

June 30, 2022

Study Completion

September 10, 2022

Last Updated

March 20, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations